Global Partnerships: Shaping the Future of Healthcare Technology

Current Landscape of Global Healthcare Partnerships

Global healthcare partnerships are thriving, with major players like Johnson & Johnson, UnitedHealth Group, GE HealthCare, Pfizer, and Microsoft driving innovation. These collaborations focus on integrating advanced technologies, enhancing patient care, and transforming healthcare delivery on a global scale.

"I want to say how much I have enjoyed getting to know Doug and the Shockwave team as we have worked through this process. We are confident in the cultural fit within our companies and believe that our shared patient centric missions, the strength of Shockwave's current and future portfolio and Johnson and Johnson's capabilities and global scale will enable us to make a profound impact on the treatment of cardiovascular disease. And now I will pass the call to Doug. Doug?" --- (JNJ, M&A Announcement, 2024/04/05)

"We're going to bring it back much stronger than it was before. And secondarily, all of the reasons that we were interested in bringing the Change Healthcare capabilities and customer connectivity closer to UnitedHealth Group still absolutely holds fast in terms of the potential innovation around things like real-time settlement, clinical decision support capabilities, all of those products are the future services of the future, which ought to be characteristics of a modern healthcare environment." --- (UNH, earning call, 2024/Q1)

"About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier." --- (GE HealthCare, press release, 2024/07/25)

"especially artificial intelligence. Digital capabilities and AI are transforming healthcare, accelerating our ability to bring new breakthroughs to patients everywhere. For years, Pfizer has been harnessing digital and AI across the entire company to drive innovation and productivity on a global scale." --- (PFE, AGM, 2024/04/25)

""We are honored to partner with SacValley MedShare on their continued journey to advance healthcare and are confident our technology, combined with our dedicated, skilled team members, will deliver the improved efficiency and support SacValley MedShare needs to achieve its healthcare transformation goals," said Dan Burton, CEO of Health Catalyst." --- (MSFT, press release, 2024/04/25)

Tech Giants and Healthcare Collaborations

Tech giants like Microsoft, Oracle, Apple, and Amazon are significantly enhancing healthcare through strategic collaborations. Microsoft's Azure AI Health Bot, Oracle's active participation in healthcare conferences, Apple's partnership with Epic Systems, and Amazon's expanding pharmacy services exemplify how these companies are driving innovation and improving healthcare delivery.

""The addition of Wired-4-Health will position Avant as a key contributor in helping healthcare organizations solve complex problems at the intersection of cost, quality, compliance and technology." Tech giant Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT) has also been aiding the healthcare sector, most notably with its Azure AI Health Bot, which helps create copilot experiences with healthcare safeguards." --- (MSFT, press release, 2024/04/25)

"For our next presentation, we're obviously pretty excited about it because this is a first for us at the Credit Suisse Healthcare Conference to be hosting technology giant, Oracle, at our conference." --- (ORCL, conference, 2024/06/05)

"We see more and more enterprise customers embracing the Mac. In Healthcare, Epic Systems, the world's largest electronic medical record provider, recently launched its native app for the Mac, making it easier for healthcare organizations like Emory Health to transition thousands of PCs to the Mac for clinical use." --- (AAPL, earning call, 2024/Q2)

"engagement in our original and partner content. Our health services business is growing robustly as customers are loving our pharmacy customer experience, and we've launched same-day delivery of prescription medications to customers in eight cities, including Los Angeles and New York City, with plans to expand to more than a dozen cities by the end of the year with customers now getting first fill medications 75% faster year-over-year nationwide." --- (AMZN, earning call, 2024/Q1)

"Tomorrow! Join @larryellison and @bfrist to hear how technology can improve healthcare globally." --- (ORCL, Twitter, 2024/04/22)

Pharmaceutical Partnerships in Drug Development

Pharmaceutical partnerships are crucial for drug development, as highlighted by Ligand's collaboration for late-stage development and commercialization, Eli Lilly's business development to expand its pipeline, and Bristol-Myers Squibb's focus on partnerships to deliver medicines. Pfizer and Merck also emphasize regional and external collaborations to enhance their development portfolios.

"Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) in order to generate its revenue." --- (MRK, press release, 2024/08/06)

"Our focus is to bring innovative medicines to people in need. And in 2024, we're investing in our people, our launches, expanding our pipeline of new medicines, including through business development, and of course accelerating the needed capacity in our manufacturing network." --- (LLY, earning call, 2024/Q1)

"Business development and partnerships remain important for us and we continued to strengthen our balance sheet while maintaining our commitment to returning cash to shareholders. Taken together, these actions are ensuring we are focused on the highest-value activities across the organization, tightening our execution where needed and accelerating our ability to deliver important medicines to patients. On that note, turning to Slide 6." --- (BMY, earning call, 2024/Q2)

"In the EU, we are developing in collaboration with the Pierre Fabre Group. In Japan, we are developing in collaboration with Ono Pharmaceutical Co., Ltd. (d) Being developed in collaboration with BMS." --- (PFE, sec filing, 2024/Q1)

"At the same time, we will continue to seek opportunities for external collaborations to specifically strengthen our development portfolio across clinical phases as we recently successfully did through collaborations agreements with Hengri Pharmaceuticals, Abisko Therapeutics and Inspirnap." --- (MRK, event transcript, 2024/04/26)

Healthcare Providers and Technology Integration

Combining robust technology platforms with strong provider bases accelerates healthcare integration, enhancing patient experiences and outcomes. Companies like Astrana, CVS, Change Healthcare, Cohere Health, and HCA are leveraging technology to improve clinical decision-making, streamline workflows, and deliver personalized, cost-effective care.

"We believe combining Astrana's robust technology platform and care model with CHS's strong provider base and deep payer partnerships will accelerate our goal of organizing and empowering providers while elevating the healthcare experience for patients throughout the country. CHS has built a highly complementary provider footprint across several states, including key markets such as Connecticut, Georgia, Maryland, New Mexico, and Virginia, as well as a scaled ecosystem of more than 350 primary care physicians across Texas, where Astrana already has a growing presence." --- (Astrana Health, press release, 2024/07/25)

"The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs." --- (CVS, sec filing, 2024/Q1)

"Change is a healthcare technology company that provides data solutions aimed at improving clinical decision making and simplifying payment processes across the healthcare system." --- (Change Healthcare, press release, 2024/05/29)

""Our solutions are rooted in the latest evidenced-based guidelines from leading medical societies and use advanced technology to align patient services within care pathways through upstream moments of influence, ultimately enabling faster diagnoses." Cohere's prior authorization platform helps providers and patients get to 'yes' more quickly." --- (Cohere Health, press release, 2024/04/23)

"🎙️ Dr. Michael Schlosser, HCA Healthcare SVP of care transformation and innovation, recently sat down with @FAHhospitals to share how innovations in technology – with clinician input and collaboration – are improving workflows for care teams. Tune in ➡️ https://t.co/zHZFJr2Vr8. https://t.co/5RY9fGHxf1" --- (HCA, Twitter post, 2024/07/25)

Regulatory Impacts on Healthcare Collaborations

Regulatory changes significantly impact healthcare collaborations by influencing market growth, operational results, and innovation timelines. Companies like UnitedHealth and Johnson & Johnson emphasize the importance of navigating regulatory milestones, while Pfizer highlights the necessity of regulatory approvals. Additionally, Google and Amazon stress the need for regulatory oversight and data privacy in healthcare technology collaborations.

"The rate of market growth may be affected by a variety of factors, including macroeconomic conditions and regulatory changes, which could impact our results of operations, including our continued efforts to control health care costs." --- (UNH, sec filing, 2024/Q1)

"As we continue to bring new innovations to market and execute against clinical and regulatory milestones, Innovative Medicine is well-positioned to achieve sustainable growth in both the near and long-term.Turning to MedTech, we continue to advance our pipeline, launch new commercial products and integrate strategic acquisitions that broaden and further differentiate our portfolio." --- (JNJ, earning call, 2024/Q2)

"(c) Being developed in collaboration with OPKO Health, Inc. (OPKO). (d) Previously authorized under EUA in the U.S. (December 2021) and approved by the FDA in high-risk adults (May 2023)." --- (PFE, sec filing, 2024/Q1)

"They are not medical practices. They do not charge for their services, lack regulatory oversight and are not covered by federal laws protecting sensitive health data." --- (GOOG, event transcript, 2024/06/07)

"This collaboration will help organizations like the District of Columbia Department of Health speed innovation, improve customer service, and improve productivity, while keeping data private and secure." --- (AMZN, press release, 2024/04/30)

Innovations from Global Healthcare Partnerships

Global healthcare partnerships are driving significant innovations, as seen with ViiV Healthcare's advances in HIV treatment through the collaboration of GSK and Pfizer, and GE HealthCare's strategic use of generative AI with AWS to transform healthcare. These partnerships exemplify the power of global collaboration in advancing healthcare technology.

"We presented data for multiple novel candidates, demonstrating our commitment to advancing standards of care and maintaining leadership over the long term. As a company, we remain highly focused and continue to work with urgency to bring forward these innovations, and others, for the patients we serve. In summary, I want to again recognize the tremendous efforts of our global team." --- (MRK, earning call, 2024/Q2)

"For more information on the FSG, please visit https://fundacionseimcgesida.org/en/quienes-somos/ About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE:PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of acquiring HIV." --- (PFE, press release, 2024/07/23)

"As the only company dedicated to both medical technology and pharmaceuticals, we are uniquely positioned to lead the next wave of health care innovation." --- (JNJ, earning call, 2024/Q2)

""GE HealthCare is putting generative AI at the heart of their innovation, accelerated by the investments we have made in healthcare-specific cloud services and generative AI capabilities that provide best-in-class security, data privacy, and access to the latest state-of-the-art foundation models." --- (AMZN, press release, 2024/07/25)

"We remain guided by our purpose of harnessing the power of leading-edge science to save and improve lives around the world.Our ambitious and dedicated teams are working tirelessly to reach more patients with our broad commercial portfolio and advance our deep pipeline with the goal of delivering future innovations that solve for additional unmet medical needs.Through excellent scientific, commercial and operational execution, we’re achieving significant milestones for our company and for patients." --- (MRK, earning call, 2024/Q2)

Challenges in Global Healthcare Collaborations

Global healthcare collaborations face challenges such as pricing, geopolitical issues, and the need for continuous technological advancements. Companies like Microsoft, Google, and Pfizer are addressing these through AI initiatives and infrastructure improvements, while Johnson & Johnson highlights the importance of practical medical technologies like Shockwave to overcome specific clinical challenges.

"Through the AI for Health program, Microsoft is working with nonprofits, researchers and organizations working on global health challenges to make advances in telemedicine and improve clinical decision-making and prediction." --- (MSFT, press release, 2024/06/10)

"continue, as we always have, to navigate some of the challenges we have on the ground with pricing and geopolitical challenges, and we remain committed to the 1.4 billion patients who rely on us each and every day. Thank you." --- (JNJ, earning call, 2024/Q2)

"From our foundation of research leadership and technical advances, including multi modality and long context, to our global product footprint that gives us opportunities to bring helpful AI to people everywhere, to our world class infrastructure that makes it all possible. Through all of these efforts, we are constantly listening to feedback, making improvements, learning and in trading." --- (GOOG, event transcript, 2024/06/07)

"Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical at Pfizer, said: "The rapid expansion of new technologies, like artificial intelligence, holds tremendous potential to help transform what is possible in human health." --- (PFE, press release, 2024/07/17)

"Delivering Shockwave in the familiar form factor of a low pressure angioplasty catheter has enabled many thousands of physicians globally to simply, safely and predictably treat these heavily calcified lesions that had long been their greatest challenge and frustration." --- (JNJ, event transcript, 2024/04/05)

Future Opportunities in Healthcare Partnerships

Future opportunities in healthcare partnerships include advancing new treatments like the mFOLFIRINOX combination for pancreatic cancer and leveraging platforms like LinkedIn to target healthcare industry professionals for strategic collaborations.

"If the mFOLFIRINOX combination shows a compelling efficacy signal, this therapeutic approach could also be advanced to a registration-enabling study, providing two opportunities for pelareorep-based treatment to benefit pancreatic cancer patients," said Thomas Heineman , M.D., Ph.D., Chief Medical Officer at Oncolytics." --- (JNJ, press release, 2024/05/09)

"If you want to target a set of CFOs that live in San Francisco that are in the healthcare industry, there's no better place to do that on LinkedIn." --- (MSFT, conference, 2024/06/06)